Oxindanac

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZY400R3BNT. European Medicines Agency schedules Oxindanac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09532MIG. Oxindanac generally arises in the molecular formula C17H14O4. The term OXINDANAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26.) OXINDANAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, OXINDANAC remains the US FDA Preferred Term for this commodity. Oxindanac bears US NLM identifiers UMLS ID C0069768 and NCI Concept Code C66268. SMILES: OC(=O)C1CCC2C1CC(O)C(C2)C(=O)C1CCCCC1.